Literature DB >> 8858218

Increased expression of low-affinity insulin receptor isoform and insulin/insulin-like growth factor-I hybrid receptors in term placenta from insulin-resistant women with gestational hypertension.

H Valensise1, Y Y Liu, M Federici, D Lauro, D Dell'anna, C Romanini, G Sesti.   

Abstract

Gestational hypertension is associated with insulin-resistance; insulin and insulin-like growth factor-1 (IGF-1), acting through their receptors, play a role in the growth of the feto-placental unit. Since both receptors are exposed to the maternal circulation, it has been suggested that maternal metabolic abnormalities might affect placental insulin (HIR) and IGF-1 (IGF-1R) receptors. To clarify this issue, we characterized HIR and IGF-1R in placenta at term from normal women, normoinsulinaemic women with gestational hypertension (NGH), and hyperinsulinaemic women with gestational hypertension (HGH). Insulin binding was decreased in HGH women (B/T 0.12 +/- 0.03) compared to control and NGH women (B/T 0.18 +/- 0.07, p < 0.036; and 0.22 +/- 0.5, p < 0.009 respectively). Receptor affinity was lower in HGH women (ED50 0.95 +/- 0.32 nmol/l) than control and NGH women (ED50 0.42 +/- 0.19 nmol/l, p < 0.01; and 0.40 +/- 0.1 nmol/l, p < 0.007, respectively), whereas low-affinity Ex11+ isoform was higher in HGH women (Ex11+ 50 +/- 7, %) than in control and NGH women (Ex11+ 34 +/- 9%, p < 0.001; and 39 +/- 4%, p < 0.01, respectively). Increased expression of Ex11+ isoform was correlated with ED50 (r = 0.71; p < 0.002) and insulinaemia (r = 0.70, p < 0.002). IGF-I binding was increased in HGH women (B/T 0.17 +/- 0.03) compared to control and NGH women (B/T 0.09 +/- 0.05, p < 0.002; and 0.11 +/- 0.03, p < 0.002, respectively). IGF-IR affinity was similar in the three groups. The percentage of insulin/IGF-I hybrid receptors was increased in HGH women (85 +/- 3%) compared to control and NGH women (68 +/- 7%, p < 0.001; and 63 +/- 9%, p < 0.001, respectively), and was positively correlated with insulinaemia (r = 0.62, p < 0.018), ED50 of insulin binding (r = 0.62, p < 0.05), and maximal IGF-I binding (r = 0.69, p < 0.004); whereas it was inversely correlated with maximal insulin binding (r = -0.69, p < 0.004). Results provide the first evidence for altered expression of insulin/IGF-I hybrids found in insulin-resistance states.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8858218     DOI: 10.1007/bf00403915

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  48 in total

1.  The classification and definition of the hypertensive disorders of pregnancy.

Authors:  D A Davey; I MacGillivray
Journal:  Am J Obstet Gynecol       Date:  1988-04       Impact factor: 8.661

2.  Different ligand affinities of the two human insulin receptor splice variants are reflected in parallel changes in sensitivity for insulin action.

Authors:  D A McClain
Journal:  Mol Endocrinol       Date:  1991-05

3.  Altered expression of insulin receptor types A and B in the skeletal muscle of non-insulin-dependent diabetes mellitus patients.

Authors:  L Mosthaf; B Vogt; H U Häring; A Ullrich
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

4.  Insulin-like growth factor I receptor beta-subunit heterogeneity. Evidence for hybrid tetramers composed of insulin-like growth factor I and insulin receptor heterodimers.

Authors:  C P Moxham; V Duronio; S Jacobs
Journal:  J Biol Chem       Date:  1989-08-05       Impact factor: 5.157

5.  Relative expression of insulin receptor isoforms does not differ in lean, obese, and noninsulin-dependent diabetes mellitus subjects.

Authors:  C M Anderson; R R Henry; P E Knudson; J M Olefsky; N J Webster
Journal:  J Clin Endocrinol Metab       Date:  1993-05       Impact factor: 5.958

6.  Effect of dexamethasone on the alternative splicing of the insulin receptor mRNA and insulin action in HepG2 hepatoma cells.

Authors:  A Kosaki; N J Webster
Journal:  J Biol Chem       Date:  1993-10-15       Impact factor: 5.157

7.  Distinct alpha-subunit structures of human insulin receptor A and B variants determine differences in tyrosine kinase activities.

Authors:  M Kellerer; R Lammers; B Ermel; S Tippmer; B Vogt; B Obermaier-Kusser; A Ullrich; H U Häring
Journal:  Biochemistry       Date:  1992-05-19       Impact factor: 3.162

8.  Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity.

Authors:  M A Soos; C E Field; K Siddle
Journal:  Biochem J       Date:  1993-03-01       Impact factor: 3.857

9.  Insulin-inducible changes in insulin receptor mRNA splice variants.

Authors:  S M Sell; D Reese; V M Ossowski
Journal:  J Biol Chem       Date:  1994-12-09       Impact factor: 5.157

10.  The relation between human fetal growth and fetal blood levels of insulin-like growth factors I and II, their binding proteins, and receptors.

Authors:  E A Reece; A Wiznitzer; E Le; C J Homko; H Behrman; E M Spencer
Journal:  Obstet Gynecol       Date:  1994-07       Impact factor: 7.661

View more
  4 in total

Review 1.  Maternal-placental-fetal interactions in the endocrine regulation of fetal growth: role of somatotrophic axes.

Authors:  Peter D Gluckman; Catherine S Pinal
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

Review 2.  Recent developments in the structural characterisation of the IR and IGF1R: implications for the design of IR-IGF1R hybrid receptor modulators.

Authors:  Samuel J Turvey; Martin J McPhillie; Mark T Kearney; Stephen P Muench; Katie J Simmons; Colin W G Fishwick
Journal:  RSC Med Chem       Date:  2022-02-21

Review 3.  The IGF-1 receptor and regulation of nitric oxide bioavailability and insulin signalling in the endothelium.

Authors:  V Kate Gatenby; Helen Imrie; Mark Kearney
Journal:  Pflugers Arch       Date:  2013-01-22       Impact factor: 3.657

4.  Effect of insulin analogues on insulin/IGF1 hybrid receptors: increased activation by glargine but not by its metabolites M1 and M2.

Authors:  Cécile Pierre-Eugene; Patrick Pagesy; Tuyet Thu Nguyen; Marion Neuillé; Georg Tschank; Norbert Tennagels; Cornelia Hampe; Tarik Issad
Journal:  PLoS One       Date:  2012-07-26       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.